$NKTR
Price history, market instrument context, member research, and related headlines in one place.
NKTR key statistics
NasdaqCMUSD
52-week range
$33.405%$109.00
Latest session $36.56–$37.74Nektar Therapeutics (NKTR) is a stock instrument quoted on NasdaqCM in USD. The most recently published price is $36.89, down $1.03 (2.72%) from the previous close of $37.92. It has traded between $36.56 and $37.74 in the latest session. Over the past year it has ranged from $33.40 to $109.00, leaving it trading near the bottom of its 52-week range. Reported volume for the session was 999.7K. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
Source-linked intelligence
Related news
Nektar Therapeutics chief R&D officer Zalevsky sells $13,388 in shares — See source for full details.
Nektar outlines REZPEG Phase III timeline with mid-2028 data and 2029 BLA plan — See source for full details.
Earnings call transcript: Nektar beats Q2 2026 EPS but stock slips after hours — See source for full details.
Loading $NKTR research…